KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Bionano Genomics (BNGO) Return on Capital Employed (2018 - 2025)

Bionano Genomics' Return on Capital Employed history spans 7 years, with the latest figure at 1.36% for Q2 2025.

  • For Q2 2025, Return on Capital Employed rose 39.0% year-over-year to 1.36%; the TTM value through Jun 2025 reached 1.36%, up 39.0%, while the annual FY2024 figure was 0.96%, 38.0% up from the prior year.
  • Return on Capital Employed for Q2 2025 was 1.36% at Bionano Genomics, up from 1.59% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 0.14% in Q2 2021 and bottomed at 2.33% in Q4 2024.
  • The 5-year median for Return on Capital Employed is 1.22% (2023), against an average of 1.06%.
  • The largest annual shift saw Return on Capital Employed soared 1989bps in 2021 before it tumbled -172bps in 2023.
  • A 5-year view of Return on Capital Employed shows it stood at 0.22% in 2021, then plummeted by -112bps to 0.47% in 2022, then plummeted by -366bps to 2.19% in 2023, then decreased by -6bps to 2.33% in 2024, then skyrocketed by 42bps to 1.36% in 2025.
  • Per Business Quant, the three most recent readings for BNGO's Return on Capital Employed are 1.36% (Q2 2025), 1.59% (Q1 2025), and 2.33% (Q4 2024).